Oxime Carbamate—Discovery of a series of novel FAAH inhibitors
Authors:
- S.Y. SitSSS.Y. Sit
- Charles M. ConwayCCCharles M. Conway
- Kai XieKXKai Xie
- Robert BertekapRBRobert Bertekap
- Clotilde BourinCBClotilde Bourin
- Kevin D. BurrisKBKevin D. Burris
- 1 February 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (3) , 1272-1277
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Binding and Inactivation Mechanism of a Humanized Fatty Acid Amide Hydrolase by α-Ketoheterocycle Inhibitors Revealed from Cocrystal StructuresJournal of the American Chemical Society, 2009
- Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory PainChemistry & Biology, 2009
- Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) InhibitorsJournal of Medicinal Chemistry, 2008
- Structure-guided inhibitor design for human FAAH by interspecies active site conversionProceedings of the National Academy of Sciences, 2008
- Novel inhibitors of fatty acid amide hydrolaseBioorganic & Medicinal Chemistry Letters, 2007
- Mechanism of Carbamate Inactivation of FAAH: Implications for the Design of Covalent Inhibitors and In Vivo Functional Probes for EnzymesChemistry & Biology, 2005
- Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors and cholesterol lowering agentsBioorganic & Medicinal Chemistry Letters, 2003
- [3-[4-(4,5-diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: Effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost bindingProstaglandins, 1997
- Inhibitors of Acyl-CoA:cholesterol O-Acyl Transferase (ACAT) as Hypocholesterolemic Agents.6.The First Water-Soluble ACAT Inhibitor with Lipid-Regulating ActivityJournal of Medicinal Chemistry, 1994
- Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted .alpha. to the oxazole ringJournal of Medicinal Chemistry, 1993